(+)-MK-801 induced social withdrawal in rats; A model for negative symptoms of schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 29, Issue 5, 2005, Pages 827-832

  Rung, Johan P ^a   Carlsson, Arvid ^a   Markinhuhta, Katarina Rydén ^b   Carlsson, Maria L ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Carlsson Research AB   (Sweden)

Author keywords

(+) MK 801; Amphetamine; Negative symptoms; Rat; Schizophrenia; Social withdrawal; Video tracking

Indexed keywords

AMPHETAMINE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL MODEL; ARTICLE; AUTOMATION; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; EVOKED RESPONSE; HUMAN; MALE; MOTOR ACTIVITY; MOVEMENT (PHYSIOLOGY); NEGATIVE SYNDROME; NONHUMAN; POSITIVE SYNDROME; PSYCHOSOCIAL WITHDRAWAL; RAT; SCHIZOPHRENIA; SOCIAL BEHAVIOR; SOCIAL INTERACTION;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL BEHAVIOR;

EID: 21244442751     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2005.03.004     Document Type: Article

References (35)

1. R.M. Allen, and S.J. Young Phencyclidine-induced psychosis Am. J. Psychiatry 135 9 1978 1081 1084
2. B. Angrist, H.K. Lee, and S. Gershon The antagonism of amphetamine-induced symptomatology by a neuroleptic Am. J. Psychiatry 131 7 1974 817 819
3. B. Angrist, G. Sathananthan, S. Wilk, and S. Gershon Amphetamine psychosis: behavioral and biochemical aspects J. Psychiatr. Res. 11 1974 13 23
4. J. Arnt Pharmacological differentiation of classical and novel antipsychotics Int. Clin. Psychopharmacol. 13 Suppl. 3 1998 S7 S14
5. P. Beamish, and L.G. Kiloh Psychoses due to amphetamine consumption J. Ment. Sci. 106 1960 337 344
6. O. Blin A comparative review of new antipsychotics Can. J. Psychiatry 44 3 1999 235 244
7. D. Boulay, R. Depoortere, C. Louis, G. Perrault, G. Griebel, and P. Soubrie SSR181507, a putative atypical antipsychotic with dopamine D(2) antagonist and 5-HT(1A) agonist activities: improvement of social interaction deficits induced by phencyclidine in rats Neuropharmacology 46 8 2004 1121 1129
8. S.A. Castner, P.S. Goldman-Rakic, and G.V. Williams Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia Psychopharmacology (Berl.) 174 1 2004 111 125
9. B.A. Ellenbroek, and A.R. Cools Animal models for the negative symptoms of schizophrenia Behav. Pharmacol. 11 3-4 2000 223 233
10. S.E. File The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs J. Neurosci. Methods 2 3 1980 219 238
11. S.E. File, and P. Seth A review of 25 years of the social interaction test Eur. J. Pharmacol. 463 1-3 2003 35 53
12. C.G. Goetz, C. Vogel, C.M. Tanner, and G.T. Stebbins Early dopaminergic drug-induced hallucinations in parkinsonian patients Neurology 51 3 1998 811 814
13. A. Jha, and H. Fourie Risperidone treatment of amphetamine psychosis Br. J. Psychiatry 174 1999 366
14. H.L. Klawans Psychiatric side effects during the treatment of Parkinson's disease J. Neural Transm., Suppl. 27 1988 117 122
15. L. Kokkinidis, and H. Anisman Amphetamine psychosis and schizophrenia: a dual model Neurosci. Biobehav. Rev. 5 4 1981 449 461
16. A.C. Lahti, B. Koffel, D. LaPorte, and C.A. Tamminga Subanesthetic doses of ketamine stimulate psychosis in schizophrenia Neuropsychopharmacology 13 1 1995 9 19
17. A.C. Lahti, M.A. Weiler, B.A. Tamara Michaelidis, A. Parwani, and C.A. Tamminga Effects of ketamine in normal and schizophrenic volunteers Neuropsychopharmacology 25 4 2001 455 467
18. D. Lodge, and N.A. Anis Effects of phencyclidine on excitatory amino acid activation of spinal interneurones in the cat Eur. J. Pharmacol. 77 2-3 1982 203 204
19. D. Lodge, M. Jones, and E. Fletcher Non-competitive antagonists of N-methyl-d-aspartate G.L. Collingridge J.C. Watkins The NMDA Receptor 1994 Oxford University Press Oxford 105 131
20. E.D. Luby, B.D. Cohen, G. Rosenbaum, J.S. Gottlieb, and R. Kelley Study of a new schizophrenomimetic drug: Sernyl Arch. Neurol. Psychiatry 81 1959 363 369
21. L. Misra, and L. Kofoed Risperidone treatment of methamphetamine psychosis Am. J. Psychiatry 154 8 1997 1170
22. M. Nilsson, A. Carlsson, K. Ryden Markinhuhta, C. Sonesson, F. Pettersson, M. Gullme, and M.L. Carlsson The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition Prog. Neuro- Psychopharmacol. Biol. Psychiatry 28 4 2004 677 685
23. F. Sams-Dodd Distinct effects of d-amphetamine and phencyclidine on the social behaviour of rats Behav. Pharmacol. 6 1 1995 55 65
24. F. Sams-Dodd Automation of the social interaction test by a video-tracking system: behavioural effects of repeated phencyclidine treatment J. Neurosci. Methods 59 2 1995 157 167
25. F. Sams-Dodd Effects of diazepam, citalopram, methadone and naloxone on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test Neurosci. Biobehav. Rev. 23 2 1998 287 293
26. F. Sams-Dodd Effects of dopamine agonists and antagonists on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test Psychopharmacology (Berl.) 135 2 1998 182 193
27. F. Sams-Dodd, B.K. Lipska, and D.R. Weinberger Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood Psychopharmacology (Berl.) 132 3 1997 303 310
28. M. Sanfilipo, A. Wolkin, B. Angrist, D.P. van Kammen, E. Duncan, S. Wieland, T.B. Cooper, E.D. Peselow, and J. Rotrosen Amphetamine and negative symptoms of schizophrenia Psychopharmacology 123 2 1996 211 214
29. S.H. Snyder Phencyclidine Nature 285 5764 1980 355 356
30. C. Tamminga Glutamatergic aspects of schizophrenia Br. J. Psychiatr., Suppl. 37 1999 12 15
31. D.P. Van Kammen, and J.J. Boronow Dextro-amphetamine diminishes negative symptoms in schizophrenia Int. Clin. Psychopharmacol. 3 2 1988 111 121
32. I.B. Weiner Differential diagnosis in amphetamine psychosis Psychiatr. Q. 38 4 1964 707 714
33. A.P. West Interaction of low-dose amphetamine use with schizophrenia in outpatients: three case reports Am. J. Psychiatry 13 3 1974 321 323
34. J.M. Wieronska, B. Szewczyk, A. Palucha, P. Branski, and M. Smialowska Involvement of CRF but not NPY in the anxiety regulation via NMDA receptors Pol. J. Pharmacol. 55 6 2003 1119 1124
35. D. Young, and W.B. Scoville Paranoid psychosis in narcolepsy and the possible danger of benzedrine treatment Med. Clin. North Am. 22 1938 637 646